Info

Ivivi Technologies, Inc. (Ivivi) is an early stage medical technology company focusing on designing, developing and commercializing electrotherapeutic technologies. Ivivi has focused its research and development activities on targeted pulsed electromagnetic field (tPEMF) technology. The Company is marketing products utilizing its tPEMF technology to the chronic wound and through its licensing partner, Allergan USA, Inc., to the plastic and reconstructive surgery markets. The Company is developing technology for other therapeutic medical markets. Based on mathematical modeling with specific biochemical signaling pathways, it develops and designs tPEMF signals, which the Company refers to as electroceuticals. In February 2008, Ivivi entered into a collaboration agreement with DSI Renal, Inc. (DSI).(Source: 10KSB)